What is the Share Price of Neuland Laboratories Ltd?

Neuland Laboratories Ltd share price is ₹15,590.25 As on 17 November, 2024|21:07

Home
>
Stocks
>
Neuland Laboratories Ltd

Neuland Laboratories Ltd Share/Stock Price

Q: What is the Market Cap of Neuland Laboratories Ltd?

The Market Cap of Neuland Laboratories Ltd is ₹20,002 As on 17 November, 2024|21:07

Q: What is PE Ratio of Neuland Laboratories Ltd?

The P/E ratio of Neuland Laboratories Ltd is 75.7 As on 17 November, 2024|21:07

Q: What is PB Ratio of Neuland Laboratories Ltd?

The PB ratio of Neuland Laboratories Ltd is 14.34 As on 17 November, 2024|21:07

₹ 15,590.25 +923.90 (6.30%)
Updated on 17-11-2024 6:56 AM

Stock Rating

Pros 3

Cons 6

Neuland Laboratories Ltd Price Performance

Day's Low
₹14,103.10

Day's High
₹16,162.05

₹ 15,590.25

52-w low
₹4,926.05

52-w high
₹16,560.75

15,590.25

Day's open
₹14,610
Previous close
₹14,666.35
VWAP
₹15,482.68
Lower price band
₹12,472.20
Upper price band
₹18,708.30

Today's Market Action

The last traded share price of Neuland Laboratories Ltd was 15,590.25 up by 6.30% on the NSE. Its last traded stock price on BSE was 15,445.05 up by 5.35%. The total volume of shares on NSE and BSE combined was 83,583 shares. Its total combined turnover was Rs 129.41 crores.

Neuland Laboratories Ltd Medium and Long Term Market Action

Neuland Laboratories Ltd hit a 52-week high of 16,560.75 on 12-11-2024 and a 52-week low of 4,926.05 on 21-12-2023. The stock price of Neuland Laboratories Ltd is up by 11% over the last one month. It is up by 195.2% over the last one year. Don't forget to check the full stock price history in the table below.

Neuland Laboratories Ltd Fundamentals

Market Cap (Cr): 20002
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Neuland Laboratories Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Neuland Laboratories Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Neuland Laboratories Ltd

Data not available.

Neuland Laboratories Ltd FAQ's

What is Share Price of Neuland Laboratories Ltd?

What is the Market Cap of Neuland Laboratories Ltd?

What is PE Ratio of Neuland Laboratories Ltd?

What is PB Ratio of Neuland Laboratories Ltd?

What is the CAGR of Neuland Laboratories Ltd?

How to Buy Neuland Laboratories Ltd Share?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Momentum Strength
The stock is currently exhibiting strong momentum, & is showing consistent strong relative strength.
High Pricing Power
The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.08. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.66. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 162 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Negative Margin of Safety
The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(17/11/2024)

Margin of Safety Index: Moderate

0.00%

0.00% People are bullish about Neuland Laboratories Ltd

100.00%

100.00 % People are bearish about Neuland Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %